Santiago Collado is a seasoned Key Account Manager at Ultragenyx, where he plays a pivotal role in advancing the company's mission to provide innovative therapies for ultrarare genetic disorders in Spain. With a robust academic background as a pharmacist and multiple advanced degrees—including a Master's...
Santiago Collado is a seasoned Key Account Manager at Ultragenyx, where he plays a pivotal role in advancing the company's mission to provide innovative therapies for ultrarare genetic disorders in Spain. With a robust academic background as a pharmacist and multiple advanced degrees—including a Master's in Clinical Trials from Tech University (2023) and an MBA from CEU San Pablo (2010)—Santiago combines scientific acumen with strategic business insights. His extensive experience in launching pharmaceutical products across various therapeutic areas, including oncology, hematology, and immunology, positions him as a valuable asset in navigating the complexities of the biotech landscape.
In his current role, Santiago is responsible for managing key accounts and fostering relationships with healthcare professionals and scientific leaders across Spain. He adeptly leverages his expertise in market analysis and hospital sales to identify opportunities for growth and enhance the accessibility of groundbreaking treatments for patients with rare diseases. His proficiency in negotiation and sales management enables him to effectively advocate for Ultragenyx's portfolio, ensuring that healthcare providers are well-informed about the latest advancements in ultrarare genetic therapies.
Santiago's commitment to collaboration is evident in his involvement in clinical trials and advisory boards, where he engages with thought leaders to drive innovation and improve patient outcomes. Reporting directly to the General Manager for the Spain-Portugal-Italy cluster, he is instrumental in shaping business strategies that align with the company's vision while remaining goal-oriented and data-driven. Through his multifaceted expertise and dedication to the field, Santiago Collado continues to make significant contributions to the healthcare landscape, ultimately improving the lives of patients affected by ultrarare genetic disorders.
